• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Healthy.io Secures $50M to Expand Smartphone Kidney Test

by Fred Pennic 05/03/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • Healthy.io, the global leader in transforming the smartphone camera into a clinical-grade device, raises $50M in a Series D funding round led by Schusterman Family Investments and is joined by Aleph and other existing shareholders. This investment, together with a previously unannounced $45 million February 2022 investment, comprises the company’s Series D.
  • The Series D round will support Healthy.io’s expansion across the U.S. market, where Minuteful Kidney™, the company’s clinical-grade kidney test and patient engagement service, has met increased demand from leading health plans, health systems, and kidney care management groups.

Empowering At-Risk Members for Chronic Kidney Disease

As rates of diabetes and hypertension continue to rise across the United States, more Americans are at risk for chronic kidney disease (CKD) but are otherwise untested and unmanaged. CKD is a leading cause of death in the country. Known as a “silent killer,” 90% of the 37 million Americans who have the disease – which disproportionately impacts underserved communities – don’t know they have it and often progress to late-stage CKD or dialysis treatments. Barriers such as a lack of awareness and transportation challenges prevent at-risk Americans from completing recommended testing, a urine albumin-creatinine ratio (uACR) test, that can detect kidney damage. 75 million Americans are recommended to complete uACR testing, yet 80% do not.

The company’s at-home urinalysis services enable providers and healthcare systems to reach high-risk, previously untested members and help close care gaps. Healthy.io partners with leading health insurers and providers to integrate Minuteful Kidney™ in their kidney management programs. Minuteful Kidney™ is marketed commercially across the United States and the United Kingdom and is the first and only FDA-cleared, smartphone-powered, at-home kidney test that allows patients to take the test in the privacy of their homes and receive immediate clinical-grade results. The service removes the barriers associated with traditional lab testing and averts the road to dialysis.

High Adherence Rates

In tests of over 250,000 patients in the U.S. and the U.K., the solution has demonstrated unprecedentedly high adherence rates of up to 50% among previously untested populations. Promoting early diagnosis of CKD can also drastically reduce the skyrocketing costs associated with CKD, which currently costs Medicare $124B a year.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: care management, diabetes, FDA, Health Systems, Healthy.io, Hypertension, Kidney Disease, medicare, Partners, patient engagement, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |